AVD-104

N/A

Report date: 2023/04/17 11:23:31

Base Information

Drug NameAVD-104
Drug Alias NameAVD-104
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsComplement factor H stimulants
TargetsComplement factor H
Therapy Area/IndicationsDiabetic macular oedemaGeographic AtrophyMacular Degeneration +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAviceda Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAviceda Therapeutics Inc
Inactive CompaniesAviceda Therapeutics Llc
Active IndicationsGeographic AtrophyMacular Degeneration
Inactive IndicationsDiabetic macular oedemaDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A